US Hospitalizations and Costs for Illicit Drug Users with Soft Tissue Infections
- 403 Downloads
Skin and soft tissue infections (SSTIs) are common complications of illicit drug use. Studies at single, urban hospitals demonstrate high rates of emergency department visits and hospitalizations for these infections. This study sought to estimate nationwide and regional incidence and costs of hospitalizations for illicit drug users with SSTIs in the US. AHRQ’s Nationwide Inpatient Sample was used to conduct a retrospective cross-sectional, time-series study. Hospitalizations of illicit drug users with SSTIs were identified using International Classification of Diseases, 9th Revision Clinical Modification codes. An estimated 106,126 hospitalizations for illicit drug users with SSTIs represented 0.07% of all US non-Federal hospitalizations from 1998 to 2001 and cost over 193 million dollars in 2001. Higher rates of hospitalization were found in the West, Northeast, and urban teaching hospitals. Hospitalization rates for illicit drug users with SSTIs vary significantly according to US region. Resources to reduce the incidence and severity of these infections should be targeted accordingly.
Keywordsdrug abuse utilization skin and soft tissue infections costs
- 8.Haverkos HW, Lange WR. From the Alcohol, Drug Abuse, and Mental Health Administration. Serious infections other than human immunodeficiency virus among intravenous drug abusers. Journal of Infectious Diseases. 1990;161(5):894–902 (published erratum appears in J Infect Dis 1990 Dec;162(6):1421).PubMedGoogle Scholar
- 10.Schnall SB, Holtom PD, Lilley JC. Abscesses secondary to parenteral abuse of drugs. A study of demographic and bacteriological characteristics. Journal of Bone & Joint Surgery – American Volume. 1994;76(10):1526–1530.Google Scholar
- 13.Ciccarone DJB, Kral AH, Edlin BR, et al. Soft tissue infections among injection drug users—San Francisco, California, 1996–2000. MMWR Weekly. 2001;50(19):381–384.Google Scholar
- 16.Office of National Drug Control Policy. The economic costs of drug abuse in the United States 1992–2002. Washington, D.C.: Executive Office of the President (Publication No. 207303); 2004.Google Scholar
- 17.U.S. Department of Health and Human Services. International classification of diseases, ninth revision, clinical modification. 5th edn. Washington: US Government Printing Office; 1999.Google Scholar
- 18.HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 2000–2001. Agency for Healthcare Research and Quality R, MD. http://www.hcup-us.ahrq.gov/nisoverview.jsp.
- 20.Anderson EJ, Hawkins C, Bolon MK, et al. A series of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes: JAIDS. 2006;41(1):125–127. doi: 10.1097/01.qai.0000192004.08153.ea.CrossRefPubMedGoogle Scholar
- 24.Centers for Disease Control and Prevention. HIV prevalence trends in selected populations in the United States: results from national serosurveillance, 1993–1997. Atlanta: Centers for Disease Control and Prevention; 2001:1–51.Google Scholar